Showing results (1591-1600 of 2,027) with videos related to

Sort By:
Pageof 203
The Journal of Clinical Endocrinology and Metabolism|April 13, 2010
Free testosterone levels are associated with mobility limitation and physical performance in community-dwelling men: the Framingham Offspring StudyJoanne B Krasnoff, Shehzad Basaria, Michael J Pencina, et al.
Proteomics|June 2, 2024
A complementary metaproteomic approach to interrogate microbiome cultivated from clinical colon biopsiesVan-An Duong, Altai Enkhbayar, Nobel Bhasin, et al.
Journal of Neuro-Oncology|May 16, 2026
Should checkpoint inhibitors be reserved for biomarker-selected pediatric brain tumors?Yaxel Levin-Carrion, Jayant Bhasin, Kevin Titkov, et al.
Plos One|September 21, 2011
Combinatorial effect of non-steroidal anti-inflammatory drugs and NF-κB inhibitors in ovarian cancer therapyLuiz F Zerbini, Rodrigo E Tamura, Ricardo G Correa, et al.
JAMA Internal Medicine|May 11, 2026
Testosterone Treatment in Prostate Cancer Survivors With Hypogonadism: A Randomized Clinical TrialShalender Bhasin, Arthur L Burnett, Thiago Gagliano-Jucá, et al.
Medrxiv : the Preprint Server for Health Sciences|February 6, 2026
Association between adipokines and glycemia in children under age 8: the PROGRESS cohort of MexicoYara S Beyh, Haotian Wu, K M Venkat Narayan, et al.
JCI Insight|December 11, 2025
First-in-child phase I trial of p-STAT3 inhibitor WP1066 in pediatric brain tumor patientsRobert C Castellino, Hope L Mumme, Andrea T Franson, et al.
Cell Reports|June 10, 2022
Baricitinib attenuates the proinflammatory phase of COVID-19 driven by lung-infiltrating monocytesBrian Dobosh, Keivan Zandi, Diego Moncada Giraldo, et al.
Journal of the American Geriatrics Society|November 19, 2020
Clinically Important Differences for Mobility Measures Derived from the Testosterone TrialsAlisa J Stephens-Shields, John T Farrar, Susan S Ellenberg, et al.
Pageof 203